XML 19 R5.htm IDEA: XBRL DOCUMENT v3.24.1
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Income Statement [Abstract]    
Net Sales $ 83,612 $ 72,810
Cost of Sales 74,908 68,733
Gross Profit 8,704 4,077
Research and Product Development 1,107 3,119
Selling and Marketing 2,125 2,094
General and Administrative 12,142 15,644
Operating Loss (6,670) (16,780)
Other Expense:    
Realized Gain on Investments 321 4
Interest Expense (2,301) (1,936)
Interest Income 211 33
Total Other Expense, net (1,769) (1,899)
Net Loss $ (8,439) $ (18,679)
Net Loss per Share, Basic (in dollars per share) $ (0.37) $ (1.31)
Net Loss per Share, Diluted (in dollars per share) $ (0.37) $ (1.31)
Weighted Average Shares Outstanding, Basic (in shares) 23,322,915 14,304,512
Weighted Average Shares Outstanding, Diluted (in shares) 23,322,915 14,304,512